Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.36 |
| ▸ | MGMT | P16455 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 13/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 13/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 13/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 13/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 11/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 8/20 | 0.33 |
| ▸ | PNP | P00491 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6265529 | 0.87 | PDE4A (0.34) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL6271387 | 0.84 | CDK1 (0.37) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL6265333 | 0.83 | PDE4A (0.46) | MGMTPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL874734 | 0.82 | ADORA2A (0.45) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL5048171 | 0.81 | PNP (0.39) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL667794 | 0.80 | PDE4A (0.49) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL6268075 | 0.80 | ADORA2A (0.34) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL6266783 | 0.80 | MGMT (0.49) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL6271696 | 0.79 | PNP (0.39) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL9960806 | 0.79 | PNP (0.38) | PDE4APDE4BPDE4CPDE4DADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1017394-B1 | CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES | CANCER REC TECH LTD (GB) | 2005-12-07 | — | — | EP | disclosed |
| US-6303618-B1 | ADMINISTERING PURINE COMPOUND WHICH INHIBITS CYCLIC DEPENDENT KINASE ACTIVITY FOR THERAPY OF TUMOR OR OTHER CELL PROLIFERATION DISORDER | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 2001-10-16 | — | — | US | disclosed |